➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Harvard Business School
AstraZeneca
Boehringer Ingelheim
McKesson

Last Updated: September 18, 2021

DrugPatentWatch Database Preview

Claims for Patent: 5,405,945

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 5,405,945
Title: DNA encoding reproductive hormones and expression using a minigene
Abstract:Expression constructs for the alpha subunit common to the four human reproductive hormones are disclosed which have enhanced efficiency. These constructs are characterized by the presence of only one intron interrupting the coding sequence for the alpha subunit.
Inventor(s): Boime; Irving (St. Louis, MO), Matzuk; Martin M. (St. Louis, MO)
Assignee: Washington University (St. Louis, MO)
Application Number:07/950,835
Patent Claims:1. A recombinant DNA molecule capable of, when contained in a recombinant host cell, expressing the gene encoding the human gonadotropin alpha subunit, said DNA molecule comprising a nucleotide sequence encoding said subunit operably linked to control sequences compatible with said host, wherein said nucleotide sequence contains one intron of the genomic nucleotide sequence encoding said alpha gonadotropin but no other introns.

2. Host cells modified to contain the recombinant DNA molecule of claim 1.

3. A method to produce human gonadotropin alpha subunit which comprises culturing the cells of claim 2 under conditions wherein the nucleotide sequence encoding the human gonadotropin alpha subunit is expressed and

recovering the human gonadotropin alpha subunit from the cell culture.

4. Recombinant host cells of claim 2 which are further modified to contain a second DNA molecule capable of expressing the nucleotide sequence encoding the beta subunit of a human glycoprotein hormone selected from the group consisting of FSH, LH, TSH and CG.

5. A method to produce a human glycoprotein hormone selected from the group consisting of FSH, LH, TSH and CG which comprises culturing the cells of claim 4 under conditions wherein the nucleotide sequences encoding the human alpha and beta subunits are expressed and

recovering the hormone from the cell culture.

6. The DNA molecule of claim 1 which further is capable of expressing a second nucleotide sequence encoding the beta subunit of a human glycoprotein hormone selected from the group consisting of FSH, LH, TSH and CG.

7. Recombinant host cells modified to contain the DNA molecule of claim 6.

8. A method to produce a human glycoprotein hormone selected from the group consisting of FSH, LH, TSH and CG which method comprises culturing the cells of claim 7 under conditions wherein the nucleotide sequences encoding the alpha subunit and beta subunit are expressed and

recovering the human glycoprotein hormone from the cell culture.

Details for Patent 5,405,945

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ⤷  Free Forever Trial Washington University (St. Louis, MO) 2012-04-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ⤷  Free Forever Trial Washington University (St. Louis, MO) 2012-04-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ⤷  Free Forever Trial Washington University (St. Louis, MO) 2012-04-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Merck
Colorcon
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.